Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Ligand-dependent down-regulation of the glucocorticoid receptor (GR) has been shown to limit hormone responsiveness, but the mechanisms involved in this process are poorly understood. The glucocorticoid receptor is a phosphoprotein that upon ligand binding becomes hyperphosphorylated, and recent evidence indicates that phosphorylation status of the glucocorticoid receptor plays a prominent role in receptor protein turnover. Because phosphorylation is a key signal for ubiquitination and proteasomal catabolism of many proteins, we evaluated whether the ubiquitin-proteasomal pathway had a role in glucocorticoid receptor down-regulation and the subsequent transcriptional response to glucocorticoids. Pretreatment of COS-1 cells expressing mouse glucocorticoid receptor with the proteasome inhibitor MG-132 effectively blocks glucocorticoid receptor protein down-regulation by the glucocorticoid dexamethasone. Interestingly, both MG-132 and a second proteasome inhibitor beta-lactone significantly enhanced hormone response of transfected mouse glucocorticoid receptor toward transcriptional activation of glucocorticoid receptor-mediated reporter gene expression. The transcriptional activity of the endogenous human glucocorticoid receptor in HeLa cells was also enhanced by MG-132. Direct evidence for ubiquitination of the glucocorticoid receptor was obtained by immunoprecipitation of cellular extracts from proteasome-impaired cells. Examination of the primary sequence of mouse, human, and rat glucocorticoid receptor has identified a candidate PEST degradation motif. Mutation of Lys-426 within this PEST element both abrogated ligand-dependent down-regulation of glucocorticoid receptor protein and simultaneously enhanced glucocorticoid receptor-induced transcriptional activation of gene expression. Unlike wild type GR, proteasomal inhibition failed to enhance significantly transcriptional activity of K426A mutant GR. Together these findings suggest a major role of the ubiquitin-proteasome pathway in regulating glucocorticoid receptor protein turnover, thereby providing a mechanism to terminate glucocorticoid responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GR is ubiquitinated at a conserved lysine residue located at position 419 (Lys-419), and this modification targets the receptor for degradation by the 26S proteasome (Fig.3B)78,79.”
From Corticosteroids (2016) · cites this paper as [79]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
Proteasome inhibitors: valuable new tools for cell biologists.
Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474
Degradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
Research works printed but not linked: 11
- Sapolsky, 2000, Endocr. Rev., 21, 55
- McKay, 1999, Endocr. Rev., 20, 435
- Bellingham, 1992, Mol. Endocrinol., 6, 2090
- Oakley, 1993, Crit. Rev. Eukaryotic Gene Expr., 3, 63
- Schmidt, 1994, Receptor, 4, 229
- Burnstein, 1994, Mol. Endocrinol., 8, 1764
- Danielsen, 1989, Cancer Res., 49, 2286
- McKay, 2000, Mol. Endocrinol., 14, 1222
- Whitesell, 1996, Mol. Endocrinol., 10, 705
- Vedeckis, 1989, Cancer Res., 49, 2295
- Nawaz, 1999, Cancer Res., 59, 372
Cited by
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Self-citationThe biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
Self-citationGlucocorticoid resistance in inflammatory diseases
Barnes, P. J., & Adcock, I. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60326-3 · Cited by 983
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Glucocorticoid receptor signaling in health and disease
Kadmiel, M., & Cidlowski, J. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.003 · Cited by 849
“residue or the E3 ligase have been shown to modulate GR activity [37] [38].”
BackgroundSelf-citationNuclear retinoid receptors and the transcription of retinoid-target genes
Bastien, J., & Rochette-Egly, C. (2004) · Gene · doi:10.1016/j.gene.2003.12.005 · Cited by 773
“It must be noted that the same conclusions could not be made for the other RAR isotype RARa, since inhibition of the proteasome by specific inhibitors did not abrogate, but amplified RARa-mediated transcription (Gianni and Rochette-Egly, unpublished observations), as described for the glucocorticoid receptor (Wallace…”
BackgroundCorticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.12.1564 · Cited by 694
“The GR can also be ubiquitinated and tagged for proteasomal degradation, implying that proteasome inhibitors might increase steroid responsiveness.(54) Increased GRb expression Increased expression of GRb has been described in patients with steroid-resistant asthma,(55,56) although this has not been confirmed in other…”
BackgroundJetten, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07003 · Cited by 673
“The ubiquitin (Ub)-proteasome system is intimately involved in chromatin structure remodeling and transcriptional control by nuclear receptors [Dace et al., 2000; Dennis et al., 2001; Ismail and Nawaz, 2005; Kinyamu et al., 2005; Poukka et al., 1999; Wallace and Cidlowski, 2001].”
BackgroundRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Self-citationA General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
“Several phosphorylation (134–140), ubiquitination (141), sumoylation (142), acetylation (76), and nitrosylation sites (143) as depicted in Figure 3 have been identified influencing GR-localization, stability, DNA binding, ligand response, and regulatory activity.”
BackgroundGlucocorticosteroids: current and future directions
Barnes, P. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 533
“…for proteasomal degra- British Journal of Pharmacology (2011) 163 29–43 35 dation by E3 ubiquitin ligases implying that proteasome inhibitors may increase glucocorticoid responsiveness, although this has not yet been demonstrated in glucocorticoid-resistant disease (Wallace and Cidlowski, 2001).”
BackgroundControlling nuclear receptors: the circular logic of cofactor cycles
Perissi, V., & Rosenfeld, M. G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1680 · Cited by 510
“However, there are also cases in which proteasome inhibition has been reported to enhance transcriptional activatio”
BackgroundGlucocorticoid receptor control of transcription: precision and plasticity via allostery
Weikum, E. R., Knuesel, M. T., Ortlund, E. A., & Yamamoto, K. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.152 · Cited by 533
One Hormone, Two Actions: Anti- and Pro-Inflammatory Effects of Glucocorticoids
Cruz-Topete, D., & Cidlowski, J. A. (2015) · Neuroimmunomodulation · doi:10.1159/000362724 · Cited by 454
Self-citationCAR and PXR: The xenobiotic-sensing receptors☆
Timsit, Y. E., & Negishi, M. (2007) · Steroids · doi:10.1016/j.steroids.2006.12.006 · Cited by 423
Targeted protein degradation: from mechanisms to clinic
Tsai, J. M., Nowak, R. P., Ebert, B. L., & Fischer, E. S. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00729-9 · Cited by 438
Molecular mechanisms of glucocorticoid action and resistance
Schaaf, M. J. M., & Cidlowski, J. A. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00263-7 · Cited by 416
Self-citationUpdate on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 397
Cytosolic HSP90 associates with and modulates the Arabidopsis RPM1 disease resistance protein
Hubert, D. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg547 · Cited by 397
“Steroid receptor levels, like RPM1 (Boyes et al., 1998), drop after signaling (Lange et al., 2000; Wallace and Cidlowski, 2001).”
BackgroundThe human glucocorticoid receptor: One gene, multiple proteins and diverse responses
ZHOU, J., & CIDLOWSKI, J. (2005) · Steroids · doi:10.1016/j.steroids.2005.02.006 · Cited by 372
Self-citationOakley, R. H., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.179325 · Cited by 373
Self-citationSchmidt, S., Rainer, J., Ploner, C., Presul, E., Riml, S., & Kofler, R. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401456 · Cited by 360
“GR expression, however, is subject to negative feedback regulation, at least in cells not undergoing GC-induced apoptosis.(48) In contrast, in cells sensitive to the cytolytic effect of GC, evidence for GR autoinduction has been provided: In multiple myeloma lines, GC sensitivity and resistance correlated with inducti…”
BackgroundCorticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats
Vendruscolo, L. F., Barbier, E., Schlosburg, J. E., Misra, K. K., Whitfield, T. W., Logrip, M. L., Rivier, C., Repunte-Canonigo, V., Zorrilla, E. P., Sanna, P. P., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0069-12.2012 · Cited by 319
“, Sr203, Ser211, Ser226), thus modulating its transcriptional activity and altering its protein stability and subcellular location (Wallace and Cidlowski, 2001; Itoh et al., 2002; Miller et al., 2005; Chen et al., 2008; Avenant et al., 2010).”
BackgroundModulation of Glucocorticoid Receptor Function via Phosphorylation
ISMAILI, N., & GARABEDIAN, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.007 · Cited by 318
Mechanisms and resistance in glucocorticoid control of inflammation
Barnes, P. J. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.018 · Cited by 317
Glucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
“Blocking mGR downmodulation via proteasomal inhibitors or via mutation of K426 enhances GR-mediated transactivation and retards GR mobility in the nucleus (232, 364).”
BackgroundNuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291
The Glucocorticoid Receptor: Coding a Diversity of Proteins and Responses through a Single Gene
Yudt, M. R., & Cidlowski, J. A. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0106 · Cited by 275
“This mutation blocks ligand-dependent GR down regulation and markedly enhances GR signaling (51).”
BackgroundSelf-citationComprehensive Overview of the Structure and Regulation of the Glucocorticoid Receptor
Vandevyver, S., Dejager, L., & Libert, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1010 · Cited by 265
Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification
Duma, D., Jewell, C. M., & Cidlowski, J. A. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.009 · Cited by 267
Self-citationThe Mineralocorticoid Receptor: A Journey Exploring Its Diversity and Specificity of Action
Pascual-Le Tallec, L., & Lombès, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0089 · Cited by 257
“Ligand-induced GR downregulation due to ubiquitinylation could be abrogated by proteasome inhibitor treatment or mutation of the ubiquitin-targeted lysine K426 that markedly increases GR transactivation combined with nuclear retention (55, 56).”
BackgroundGlucocorticoid receptor isoforms generate transcription specificity
Lu, N. Z., & Cidlowski, J. A. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.04.005 · Cited by 248
Self-citationGlucocorticoid receptor physiology
Heitzer, M. D., Wolf, I. M., Sanchez, E. R., Witchel, S. F., & DeFranco, D. B. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9059-8 · Cited by 235
“Like all steroid receptors, GR is primarily degraded via the ubiquitin/proteasome-dependent protein degradation pathway (UPP) [85].”
BackgroundThe significance of glucocorticoid pulsatility
Lightman, S. L., Wiles, C. C., Atkinson, H. C., Henley, D. E., Russell, G. M., Leendertz, J. A., McKenna, M. A., Spiga, F., Wood, S. A., & Conway-Campbell, B. L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.073 · Cited by 241
“It is well established that ligand activated glucocorticoid receptor is both a substrate for ubiquitination and a target for degradation by the proteasome (Deroo et al., 2002; Garside et al., 2006; Kinyamu and Archer, 2003; Wallace and Cidlowski, 2001; Wang et al., 2002).”
BackgroundPost-Translational Modifications of Nuclear Receptors and Human Disease
Anbalagan, M., Huderson, B., Murphy, L., & Rowan, B. G. (2012) · Nuclear Receptor Signaling · doi:10.1621/nrs.10001 · Cited by 211
“…122, 150, 212, 220, 234, 315, 412, and threonine 159 to alanine) inhibited ligand-dependent GR degradation and consequently, GR-mediated transcriptional activity [Wallace and Cidlowski, 2001; Webster et al., 1997], which indicated yet another NR ubiquitination that is phosphorylation-dependent.”
Vijayan, M. M., Raptis, S., & Sathiyaa, R. (2003) · General and Comparative Endocrinology · doi:10.1016/s0016-6480(03)00092-3 · Cited by 218
Post-translational modifications of steroid receptors
Faus, H., & Haendler, B. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.07.082 · Cited by 209
The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms
LU, N. Z., & CIDLOWSKI, J. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.008 · Cited by 216
Self-citationMolecular mechanisms in the regulation of adult neurogenesis during stress
Egeland, M., Zunszain, P. A., & Pariante, C. M. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3855 · Cited by 203
Involvement of Proteasome in the Dynamic Assembly of the Androgen Receptor Transcription Complex
Kang, Z., Pirskanen, A., Jänne, O. A., & Palvimo, J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209074200 · Cited by 198
Transcription in four dimensions: nuclear receptor‐directed initiation of gene expression
Métivier, R., Reid, G., & Gannon, F. (2006) · EMBO reports · doi:10.1038/sj.embor.7400626 · Cited by 194
“For instance, inhibition of the proteasome stimulates GR activity, which is in direct contrast to ER, although both NRs become immobilized on proteasome inhibition (Reid et al, 2003; Wallace & Cidlowski, 2001).”
BackgroundExpression and Degradation of Androgen Receptor: Mechanism and Clinical Implication
Lee, D. K., & Chang, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030261 · Cited by 183
Molecular mechanisms regulating glucocorticoid sensitivity and resistance
Gross, K. L., Lu, N. Z., & Cidlowski, J. A. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.001 · Cited by 180
Self-citationRole of Proteasomes in Cellular Regulation
(2008) · International Review of Cell and Molecular Biology · doi:10.1016/s1937-6448(08)00602-3 · Cited by 175
Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation
Gaughan, L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki141 · Cited by 174
“For example, both the oestrogen receptor (ER) (18–20) and glucocorticoid receptor (21,22) are rapidly ubiquitylated and destroyed after binding to their cognate hormone, suggestive of a highly acute transcriptional regulatory process.”
BackgroundGlucocorticoids and endothelial cell barrier function
Salvador, E., Shityakov, S., & Förster, C. Y. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1762-z · Cited by 172
“GR transactivation by GC binding has been found to be maintained through the overexpression of a GR mutant resistant to proteasomal degradation (GR-K426A mutant; Wallace and Cidlowski 2001).”
BackgroundDeroo, B. J., Rentsch, C., Sampath, S., Young, J., DeFranco, D. B., & Archer, T. K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4113-4123.2002 · Cited by 164
“The protein levels of many steroid hormone receptors are regulated by ubiquitin-mediated degradation via the 26S proteasome (6, 21, 28, 29, 45).”
BackgroundInfluentialGalliher-Beckley, A. J., Williams, J. G., & Cidlowski, J. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05866-11 · Cited by 164
“There are several mechanisms for expanding the plasticity of glucocorticoid signaling, including receptor isoforms and posttranslational modifications, such as phosphorylation, ubiquitination, and SUMOylation (23, 29, 43).”
BackgroundSelf-citationAutoregulation of glucocorticoid receptor by cortisol in rainbow trout hepatocytes
Sathiyaa, R., & Vijayan, M. M. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00448.2002 · Cited by 159
“The ubiquitin-proteasomal pathway is thought to play a key role in this GR-signaling process (35).”
InfluentialOwen, D., & Matthews, S. G. (2003) · Endocrinology · doi:10.1210/en.2002-0145 · Cited by 155
Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells
Schlossmacher, G., Stevens, A., & White, A. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0135 · Cited by 157
“Decreased expression of the GR may occur through decreased activity of the GR promoter, decreased mRNA stability (Schaaf & Cidlowski 2002), or decreased protein stability (Wallace & Cidlowski 2001).”
BackgroundSelective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor
Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-07 · Cited by 160
“2B), indicating that all GR isoforms are fully capable of undergoing ligand-dependent downregulation (31).”
BackgroundSelf-citationPotentiation of glucocorticoid receptor transcriptional activity by sumoylation
Le Drean, Y., Mincheneau, N., Le Goff, P., & Michel, D. (2002) · Endocrinology · doi:10.1210/en.2002-220135 · Cited by 159
Kinyamu, H. K., & Archer, T. K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5867-5881.2003 · Cited by 157
“Germane to our current studies, the ubiquitinproteasome pathway has been shown to degrade the GR (16, 65, 71, 73).”
BackgroundMechanisms of Glucocorticoid Action During Development
Busada, J. T., & Cidlowski, J. A. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.12.004 · Cited by 168
Self-citationLigand‐dependent switching of ubiquitin–proteasome pathways for estrogen receptor
Tateishi, Y., Kawabe, Y.-I., Chiba, T., Murata, S., Ichikawa, K., Murayama, A., Tanaka, K., Baba, T., Kato, S., & Yanagisawa, J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600472 · Cited by 170
“Several lines of evidence indicate that estrogen, progesterone and glucocorticoid receptors (GRs) are degraded in the presence of their cognate ligands (Nawaz et al, 1999a; Wallace and Cidlowski, 2001).”
BackgroundHsp90: an emerging target for breast cancer therapy
Beliakoff, J., & Whitesell, L. J. (2004) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000136876.11928.be · Cited by 176
Lange, C. A. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0331 · Cited by 150
“not appear to fall into this category (53, 54).”
BackgroundGlucocorticoids and chronic inflammation
Straub, R. H., & Cutolo, M. (2016) · Rheumatology · doi:10.1093/rheumatology/kew348 · Cited by 149
Glucocorticoid-Induced Apoptosis of Healthy and Malignant Lymphocytes
Smith, L. K., & Cidlowski, J. A. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82001-1 · Cited by 144
“Furthermore, GR contains a conserved proline, glutamic acid, serine and threonine (PEST) degradation motif, also contributing to the destabilization of GR protein (Wallace and Cidlowski, 2001).”
BackgroundSelf-citationRamamoorthy, S., & Cidlowski, J. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01151-12 · Cited by 146
Self-citationChecks and balances: The glucocorticoid receptor and NFĸB in good times and bad
Bekhbat, M., Rowson, S. A., & Neigh, G. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.05.001 · Cited by 131
Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex
Wiper‐Bergeron, N., Wu, D., Pope, L., Schild‐Poulter, C., & Haché, R. J. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg218 · Cited by 158
Exploring the Molecular Mechanisms of Glucocorticoid Receptor Action from Sensitivity to Resistance
Ramamoorthy, S., & Cidlowski, J. A. (2013) · Endocrine Development · doi:10.1159/000342502 · Cited by 134
“contributes to increased turnover of the GR protein in a ligand-dependent manner [11, 21].”
BackgroundSelf-citationThe Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Nawaz, Z., & O’Malley, B. W. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0388 · Cited by 132
The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process
Chymkowitch, P., May, N. L., Charneau, P., Compe, E., & Egly, J. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.337 · Cited by 130
“The interplay between these two processes was shown for the recycling of other nuclear receptors, such as the glucocorticoid receptor GR or the RARg2, which is crucial for the control of their transactivation activity (Wallace and Cidlowski, 2001; Bour et al, 2007).”
BackgroundWest-Szymanski, D. C., Pan, D., Tonsing-Carter, E. Y., Hernandez, K. M., Pierce, C. F., Styke, S. C., Bowie, K. R., Garcia, T. I., Kocherginsky, M., & Conzen, S. D. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0433 · Cited by 144
“S2), despite low-level steady-state GR (dexamethasone) and ER (dexamethasone/E2) due to ligandinduced receptor degradation (54, 55).”
BackgroundConway-Campbell, B. L., McKenna, M. A., Wiles, C. C., Atkinson, H. C., de Kloet, E. R., & Lightman, S. L. (2007) · Endocrinology · doi:10.1210/en.2007-0585 · Cited by 125
Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice
Whirledge, S., & DeFranco, D. B. (2018) · Endocrinology · doi:10.1210/en.2017-00728 · Cited by 126
“The functional diversity of glucocorticoid signaling is further ex t nded by post-translational modifications of GR, which can regulate GR nuclear translocation, de termine protein interaction surfaces, and dictate the transcriptional response to GR binding (16,17).”
BackgroundRegulation of apoptosis by the ubiquitin and proteasome pathway
Wójcik, C. (2002) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2002.tb00309.x · Cited by 118
Regulation of androgen receptor levels: Implications for prostate cancer progression and therapy
Burnstein, K. L. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20460 · Cited by 118
Newton, R., Leigh, R., & Giembycz, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.003 · Cited by 132
Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids
Dvořák, Z., & Pávek, P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602532.2010.484462 · Cited by 122
“…immunological, and hormonal processes and pathways (Gross and Cidlowski, 2008; De Bosscher et al., 2000; DeFranco, 2002; Gottlicher et al., 1998; Herrlich, 2001; Wallace and Cidlowski, 2001; Yudt and Cidlowski, 2001; Revollo and Cidlowski, 2009; Biddie and Hager, 2009; George et al., 2009).”
BackgroundLinking the ubiquitin–proteasome pathway to chromatin remodeling/modification by nuclear receptors
Kinyamu, H. K., Chen, J., & Archer, T. K. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01680 · Cited by 112
“The GR upon ligand binding is hyperphosphorylated and degraded via the ubiquitin– proteasome pathway (Webster et al. 1997, Wallace & Cidlowski 2001, Ismaili & Garabedian 2004).”
BackgroundInfluentialSano, M., Tokudome, S., Shimizu, N., Yoshikawa, N., Ogawa, C., Shirakawa, K., Endo, J., Katayama, T., Yuasa, S., Ieda, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703634200 · Cited by 114
Glucocorticoid receptor and breast cancer
Vilasco, M., Communal, L., Mourra, N., Courtin, A., Forgez, P., & Gompel, A. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1689-6 · Cited by 122
“Finally, in addition to being implicated in GR direct function, phosphorylation events play a role in the stability and halflife of GR by orientating the receptor toward proteasomal degradation following ubiquitination [ 41 , 42].”
BackgroundCross Talk of Signaling Pathways in the Regulation of the Glucocorticoid Receptor Function
Davies, L., Karthikeyan, N., Lynch, J. T., Sial, E.-A., Gkourtsa, A., Demonacos, C., & Krstic-Demonacos, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0360 · Cited by 109
Melatonin synthesized by T lymphocytes as a ligand of the retinoic acid-related orphan receptor
Lardone, P. J., Guerrero, J. M., Fernández-Santos, J. M., Rubio, A., Martín‐Lacave, I., & Carrillo‐Vico, A. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00909.x · Cited by 116
“In addition to ligand binding, phosphorylation of nuclear receptors by signal transduction pathways and co-regulator binding also serve as signals to the Ub–proteasome complex, targeting the receptor for degradation [50, 52].”
BackgroundValley, C. C., Métivier, R., Solodin, N. M., Fowler, A. M., Mashek, M. T., Hill, L. M., & Alarid, E. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5417-5428.2005 · Cited by 122
“Several members of the nuclear receptor superfamily are substrates for the ubiquitin-proteasome pathway (11, 19, 21, 24, 26, 29, 37, 50, 52, 55), the first identified being estrogen receptor (ER ) (1, 13, 36).”
BackgroundModulation of Steroid Hormone Receptor Activity
Stanišić, V., Lonard, D. M., & O’Malley, B. W. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81009-6 · Cited by 118
Navigating Steroid Hormone Receptors through the Nuclear Compartment
DeFranco, D. B. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1449 · Cited by 111
“(35) and stably integrated templates (DeRoo, B.”
Chromatin remodeling by nuclear receptors
Hebbar, P. B., & Archer, T. (2003) · Chromosoma · doi:10.1007/s00412-003-0232-x · Cited by 120
Glucocorticoids and their receptors: Insights into specific roles in mitochondria
Lee, S., Kim, H. K., Song, I.-S., Youm, J., Dizon, L. A., Jeong, S.-H., Ko, T.-H., Heo, H.-J., Ko, K. S., Rhee, B. D., et al. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.04.001 · Cited by 111
“The GR is primarily metabolized via the ubiquitin/proteasome-dependent protein degradation pathway (Wallace and Cidlowski, 2001; Weber et al., 2002).”
BackgroundKinetic Complexity of the Global Response to Glucocorticoid Receptor Action
John, S., Johnson, T. A., Sung, M.-H., Biddie, S. C., Trump, S., Koch-Paiz, C. A., Davis, S. R., Walker, R., Meltzer, P. S., & Hager, G. L. (2009) · Endocrinology · doi:10.1210/en.2008-0863 · Cited by 102
Molecular interactions between glucocorticoids and long-acting β2-agonists
Adcock, I. M., Maneechotesuwan, K., & Usmani, O. S. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129705 · Cited by 107
Burgdorf, S., Leister, P., & Scheidtmann, K. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313703200 · Cited by 98
Retinoid‐related orphan receptors (RORs): Roles in cellular differentiation and development
Jetten, A. M., & Joo, J. H. (2006) · Advances in developmental biology · doi:10.1016/s1574-3349(06)16010-x · Cited by 98
“…(Ub)proteasome system is intimately involved in regulating chromatin structure remodeling and in the transcriptional control by a number of nuclear receptors (Dace et al., 2000; Dennis et al., 2001; Ismail and Nawaz, 2005; Kinyamu et al., 2005; Poukka et al., 1999; Wallace and Cidlowski, 2001).”
BackgroundKleinschnitz, C., Blecharz, K., Kahles, T., Schwarz, T., Kraft, P., Göbel, K., Meuth, S. G., Burek, M., Thum, T., Stoll, G., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.592238 · Cited by 94
Inhibiting Proteasomal Proteolysis Sustains Estrogen Receptor-α Activation
Fan, M., Nakshatri, H., & Nephew, K. P. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0164 · Cited by 86
Glucocorticoid resistance as a major drive in sepsis pathology
Dendoncker, K., & Libert, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.002 · Cited by 85
“within a PEST element) targets GR to the proteasome and leads to GR downregulation and subsequent diminished transcriptional response to GC [146].”
BackgroundHe, Y., Xu, Y., Zhang, C., Gao, X., Dykema, K. J., Martin, K. R., Ke, J., Hudson, E. A., Khoo, S. K., Resau, J. H., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001450 · Cited by 83
Lonard, D. M., Tsai, S. Y., & O’Malley, B. W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.14-24.2004 · Cited by 93
Kelly, A., Bowen, H., Jee, Y.-K., Mahfiche, N., Soh, C., Lee, T., Hawrylowicz, C., & Lavender, P. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.010 · Cited by 83
Faresse, N. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.015 · Cited by 84
Glucocorticoid Receptor and Ubiquitin Expression after Repeated Eccentric Exercise
WILLOUGHBY, D. S., TAYLOR, M., & TAYLOR, L. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000099100.83796.77 · Cited by 78
Modifying chromatin to permit steroid hormone receptor-dependent transcription
Kinyamu, H. K., & Archer, T. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.09.015 · Cited by 92
Sevilla, L. M., Jiménez‐Panizo, A., Alegre‐Martí, A., Estébanez‐Perpiñá, E., Caelles, C., & Pérez, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810049 · Cited by 85
“For example, GR phosphorylation has a prominent role in receptor turnover mediated by K419 ubiquitination [70,71].”
Background
Metadata
- Authors
- Wallace, A. D., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Cidlowski, John A.
- ORCID
- Cidlowski, John A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 276
- Issue
- 46
- Pages
- 42714-42721
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984573021
- Cited by
- 394
- References
- 65
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 17 · 2018: 12 · 2017: 14 · 2016: 10 · 2015: 16 · 2014: 15 · 2013: 25 · 2012: 19
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6924 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- glucocorticoid receptor, receptor down-regulation, ubiquitin-proteasome system, proteasome inhibition, MG132, dexamethasone, receptor phosphorylation, ubiquitination, transcriptional activation, hormone responsiveness
- MeSH terms
- Animals, Cysteine Endopeptidases, Dexamethasone, Glucocorticoids, HeLa Cells, Humans, Ligands, Luciferases, Lysine, Multienzyme Complexes, Mutation, Phosphorylation, Plasmids, Precipitin Tests, Receptors, Glucocorticoid, Time Factors, Transcription, Genetic, Transfection, Blotting, Western, Signal Transduction, Chloramphenicol O-Acetyltransferase, Transcriptional Activation, Down-Regulation, Mutagenesis, Site-Directed, COS Cells, Amino Acid Motifs, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.